pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-13
DOI
10.1038/s41598-019-49522-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
- (2018) Wen-Yu Hsu et al. Frontiers in Psychiatry
- Redox Proteomics and Amyloid β-Peptide: Insights into Alzheimer Disease
- (2018) D Allan Butterfield et al. JOURNAL OF NEUROCHEMISTRY
- Brain aging and neurodegeneration: from a mitochondrial point of view
- (2017) Amandine Grimm et al. JOURNAL OF NEUROCHEMISTRY
- Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain
- (2017) Vinita Jagannath et al. Frontiers in Neuroanatomy
- Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging
- (2017) Chieh-Hsin Lin et al. Scientific Reports
- Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View
- (2017) Vinita Jagannath et al. Frontiers in Molecular Neuroscience
- Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- Genetic Variation in the G720/G30 Gene Locus (DAOA) Influences the Occurrence of Psychotic Symptoms in Patients with Alzheimer's Disease
- (2017) Emilio Di Maria et al. JOURNAL OF ALZHEIMERS DISEASE
- Decreased level of serum autoantibody against LG72 is a biosignature of amyotrophic lateral sclerosis
- (2016) Chi-Shin Hwang et al. Biomarkers in Medicine
- G72 primate-specific gene: a still enigmatic element in psychiatric disorders
- (2016) Silvia Sacchi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Mutation inDAOAModifies the Age of Onset inPSEN1E280A Alzheimer’s Disease
- (2016) Jorge I. Vélez et al. NEURAL PLASTICITY
- Fractality of sensations and the brain health: the theory linking neurodegenerative disorder with distortion of spatial and temporal scale-invariance and fractal complexity of the visible world
- (2015) Marina V. Zueva Frontiers in Aging Neuroscience
- d-serine levels in Alzheimer’s disease: implications for novel biomarker development
- (2015) C Madeira et al. Translational Psychiatry
- Identification of the Mitochondrial MSRB2 as a Binding Partner of LG72
- (2014) David-Marian Otte et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease
- (2014) Chieh-Hsin Lin et al. CURRENT PHARMACEUTICAL DESIGN
- Unveiling complexity: non-linear and fractal analysis in neuroscience and cognitive psychology
- (2014) Tobias A. Mattei Frontiers in Computational Neuroscience
- Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2013) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- The C-Terminal Region of G72 Increases D-Amino Acid Oxidase Activity
- (2013) Sunny Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals
- (2013) C-H Lin et al. MOLECULAR PSYCHIATRY
- Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia
- (2013) Chieh-Hsin Lin et al. SCHIZOPHRENIA RESEARCH
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease
- (2012) Yu-Jhen Huang et al. Current Neuropharmacology
- Involvement of the primate specific gene G72 in schizophrenia: From genetic studies to pathomechanisms
- (2012) Eva Drews et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Simultaneous determination of d-amino acids by the coupling method of d-amino acid oxidase with high-performance liquid chromatography
- (2010) Shiro Kato et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression
- (2009) F. Gardoni et al. JOURNAL OF NEUROSCIENCE
- l-Serine synthesis in the central nervous system: A review on serine deficiency disorders
- (2009) L. Tabatabaie et al. MOLECULAR GENETICS AND METABOLISM
- Donepezil delays progression to AD in MCI subjects with depressive symptoms
- (2009) P. H. Lu et al. NEUROLOGY
- pLG72 Modulates Intracellular D-Serine Levels through Its Interaction with D-Amino Acid Oxidase
- (2008) Silvia Sacchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started